Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China · Delayed Price · Currency is CNY 17.25
+0.23 (1.35%)
Apr 15, 2026, 3:00 PM CST
SHA:601607 Revenue
In the year 2025, Shanghai Pharmaceuticals Holding had annual revenue of 283.58B CNY with 3.03% growth. Shanghai Pharmaceuticals Holding had revenue of 68.51B in the quarter ending December 31, 2025, with 4.40% growth.
Revenue
283.58B
Revenue Growth
+3.03%
P/S Ratio
0.20
Revenue / Employee
5.72M
Employees
49,608
Market Cap
57.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 283.58B | 8.33B | 3.03% |
| Dec 31, 2024 | 275.25B | 14.96B | 5.75% |
| Dec 31, 2023 | 260.30B | 28.31B | 12.21% |
| Dec 31, 2022 | 231.98B | 16.16B | 7.49% |
| Dec 31, 2021 | 215.82B | 23.92B | 12.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jointown Pharmaceutical Group | 157.71B |
| C.Q. Pharmaceutical Holding | 83.08B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.66B |
| China National Accord Medicines Corporation | 73.42B |
| China National Medicines Corporation | 52.47B |
| China Meheco Group | 33.23B |
| Guangxi LiuYao Group | 20.95B |
| Liaoning Cheng Da | 11.12B |